BRAF and melanoma: Currently available cell-based models of drug-resistant melanoma are derived either from BRAF V600E melanomas that have been subjected to prolonged small molecule BRAF inhibition, or from cells overexpressing exogenous copies of the gene in question from a non-native promoter [9,10,11].